Days with restricted activites: coefficient (95 % CI) | ||||||
---|---|---|---|---|---|---|
Demographic-adjusted model | Fully adjusted model a | Demographic-adjusted model | Adjusted a | |||
Biomarker at baseline | CRP (mg/dL) | 0.4 (−0.2 to 0.9), p = 0.169 | 0.3 (−0.3 to 0.9), p = 0.324 | Biomarker on day 7 | 0.7 (0.1 to 1.4), p = 0.035 | 0.6 (−0.1 to 1.3), p = 0.075 |
CRP ≤20 | Reference group | Reference group | Reference group | Reference group | ||
CRP 20-50 | 0.4 (−0.5 to 1.3), p = 0.37 | 0.4 (−0.5 to 1.3), p = 0.407 | 0.7 (−0.6 to 2.0), p = 0.264 | 0.8 (−0.5 to 2.1), p = 0.252 | ||
CRP 50-100 | 0.0 (−1.0 to 1.0), p = 0.956 | −0.1 (−1.0 to 0.9), p = 0.920 | 2.5 (0.3 to 4.7), p = 0.024 | 2.4 (0.2 to 4.5), p = 0.035 | ||
CRP >100 | 1.6 (0.5 to 2.6), p = 0.005 | 1.4 (0.3 to 2.5), p = 0.014 | 3.3 (0.5 to 6.2), p = 0.022 | 2.7 (−0.3 to 5.7), p = 0.078 | ||
PCT (μg/L) | 0.9 (0 to 1.9), p = 0.048 | 0.8 (−0.2 to 1.8), p = 0.123 | 0.7 (−0.6 to 2.1), p = 0.297 | 0.5 (−0.9 to 1.9), p = 0.484 | ||
PCT ≤0.1 | Reference group | Reference group | Reference group | Reference group | ||
PCT 0.1-0.25 | 0.4 (−0.4 to 1.2), p = 0.320 | 0.3 (−0.5 to 1.1), p = 0.407 | 0.6 (−0.4 to 1.6), p = 0.249 | 0.5 (−0.5 to 1.5), p = 0.353 | ||
PCT 0.25-0.5 | 1.6 (−1.3 to 4.4), p = 0.288 | 1.2 (−1.8 to 4.1), p = 0.434 | 2.9 (−1.5 to 7.3), p = 0.194 | 2.3 (−2.1 to 6.7), p = 0.300 | ||
PCT >0.5 | 2.0 (0.0 to 4.0), p = 0.045 | 1.8 (−0.3 to 3.8), p = 0.089 | −0.3 (−4.6 to 4.1), p = 0.900 | −0.7 (−5.1 to 3.7), p = 0.751 | ||
Persistence of discomfort after 14 days: coefficient (95 % CI) | ||||||
Demographic-adjusted model | Adjusted a | Demographic-adjusted model | Adjusted a | |||
Biomarker at baseline | CRP (mg/dL) | 1.0 (0.8 to 1.4), p = 0.831 | 1.0 (0.8 to 1.4), p = 0.828 | Biomarker on day 7 | 1.7 (1.2 to 2.4), p = 0.005 | 1.7 (1.2 to 2.5), p = 0.005 |
CRP ≤20 | Reference group | Reference group | Reference group | Reference group | ||
CRP 20-50 | 1.2 (0.7 to 1.9), p = 0.517 | 1.2 (0.7 to 2), p = 0.436 | 1.6 (0.8 to 3.2), p = 0.203 | 1.7 (0.8 to 3.4), p = 0.166 | ||
CRP 50-100 | 1.0 (0.6 to 1.8), p = 0.862 | 1.1 (0.6 to 1.8), p = 0.828 | 3.4 (0.9 to 13.1), p = 0.078 | 3.4 (0.8 to 13.5), p = 0.085 | ||
CRP >100 | 1.2 (0.7 to 2.2), p = 0.477 | 1.2 (0.7 to 2.3), p = 0.514 | 6.4 (0.7 to 54.8), p = 0.091 | 4.5 (0.5 to 40.9), p = 0.18 | ||
PCT (μg/L) | 1.1 (0.6 to 1.7), p = 0.845 | 1.0 (0.6 to 1.7), p = 0.939 | 0.9 (0.4 to 1.9), p = 0.804 | 0.8 (0.4 to 1.7), p = 0.588 | ||
PCT ≤0.1 | Reference group | Reference group | Reference group | Reference group | ||
PCT 0.1-0.25 | 0.8 (0.5 to 1.3), p = 0.439 | 0.8 (0.5 to 1.3), p = 0.466 | 1.1 (0.7 to 1.9), p = 0.655 | 1.1 (0.6 to 1.9), p = 0.738 | ||
PCT 0.25-0.5 | 3.3 (0.6 to 18.0), p = 0.166 | 2.9 (0.5 to 16.3), p = 0.229 | 2.5 (0.2 to 28.5), p = 0.460 | 1.8 (0.2 to 21.4), p = 0.63 | ||
PCT >0.5 | 1.6 (0.5 to 4.7), p = 0.402 | 1.5 (0.5 to 4.5), p = 0.486 | 0.5 (0.0 to 5.7), p = 0.540 | 0.3 (0.0 to 4.6), p = 0.42 |